Shine Technologies Partners with Blue Earth Therapeutics for First Supply of Ilumira from Its New Facility
Blue Earth Therapeutics will leverage Shine's non-carrier added lutetium-177 chloride, Ilumira, in a new treatment for prostate cancer undergoing clinical trials